Phenotypic maturation as determined by CD13 and CD33 correlates to morphological differentiation
. | Gates, % . | . | . | ||
|---|---|---|---|---|---|
. | 1 . | 2 . | 3 . | ||
| Blasts | 4 | 1 | 4 | ||
| Promyelocytes | 41 | 29 | 1 | ||
| Myelocytes | 6 | 8 | 0 | ||
| Neutrophils | 38 | 58 | 9 | ||
| Macrophages/monocytes | 8 | 4 | 86 | ||
| Erythropoiesis | 3 | 0 | 0 | ||
. | Gates, % . | . | . | ||
|---|---|---|---|---|---|
. | 1 . | 2 . | 3 . | ||
| Blasts | 4 | 1 | 4 | ||
| Promyelocytes | 41 | 29 | 1 | ||
| Myelocytes | 6 | 8 | 0 | ||
| Neutrophils | 38 | 58 | 9 | ||
| Macrophages/monocytes | 8 | 4 | 86 | ||
| Erythropoiesis | 3 | 0 | 0 | ||
Differential counts of 2 to 300 cells on day 14 in myeloid expansion medium within gates 1 (CD33+ CD13-), 2 (CD33+ CD13lo), and 3 (CD33+ CD13hi).